Renaissance Technologies (RenTech)'s XTNT Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 987,410 shares of Xtant Medical Holdings, Inc. (XTNT) worth $550,975, representing 0.00% of the portfolio. First purchased in 2018-Q1, this long-term strategic position has been held for 33 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in XTNT, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2021, adding 294,081 shares. Largest reduction occurred in Q3 2021, reducing 331,200 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Xtant Medical Holdings (XTNT) Holding Value Over Time
Track share changes against reported price movement
Quarterly Xtant Medical Holdings (XTNT) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +67,550 | Add 7.34% | 987,410 | $0.56 |
| Q4 2025 | +205,945 | Add 28.85% | 919,860 | $0.78 |
| Q3 2025 | +63,205 | Add 9.71% | 713,915 | $0.65 |
| Q2 2025 | -60,500 | Reduce 8.51% | 650,710 | $0.74 |
| Q1 2025 | -86,823 | Reduce 10.88% | 711,210 | $0.47 |
| Q4 2024 | +103,825 | Add 14.96% | 798,033 | $0.44 |
| Q3 2024 | -9,602 | Reduce 1.36% | 694,208 | $0.68 |
| Q2 2024 | -59,500 | Reduce 7.79% | 703,810 | $0.63 |
| Q1 2024 | +22,400 | Add 3.02% | 763,310 | $1.17 |
| Q4 2023 | +71,172 | Add 10.63% | 740,910 | $1.13 |
| Q3 2023 | +72,728 | Add 12.18% | 669,738 | $1.10 |
| Q2 2023 | -5,800 | Reduce 0.96% | 597,010 | $0.00 |
| Q1 2023 | -3,500 | Reduce 0.58% | 602,810 | $0.00 |
| Q4 2022 | -20,900 | Reduce 3.33% | 606,310 | $0.00 |
| Q3 2022 | -43,690 | Reduce 6.51% | 627,210 | $0.72 |
| Q2 2022 | +4,700 | Add 0.71% | 670,900 | $0.52 |
| Q1 2022 | -55,400 | Reduce 7.68% | 666,200 | $0.68 |
| Q4 2021 | +40,800 | Add 5.99% | 721,600 | $0.56 |
| Q3 2021 | -331,200 | Reduce 32.73% | 680,800 | $1.11 |
| Q2 2021 | +90,229 | Add 9.79% | 1.01 M | $1.63 |
| Q1 2021 | +294,081 | Add 46.85% | 921,771 | $2.36 |
| Q4 2020 | +251,002 | Add 66.63% | 627,690 | $1.20 |
| Q3 2020 | +152,000 | Add 67.65% | 376,688 | $0.82 |
| Q2 2020 | +135,927 | Add 153.14% | 224,688 | $0.90 |
| Q1 2020 | +4,700 | Add 5.59% | 88,761 | $0.66 |
| Q4 2019 | +3,300 | Add 4.09% | 84,061 | $1.59 |
| Q3 2019 | +6,100 | Add 8.17% | 80,761 | $2.84 |
| Q2 2019 | +7,500 | Add 11.17% | 74,661 | $3.00 |
| Q1 2019 | +11,113 | Add 19.83% | 67,161 | $3.05 |
| Q4 2018 | +5,700 | Add 11.32% | 56,048 | $1.61 |
| Q3 2018 | +6,700 | Add 15.35% | 50,348 | $3.85 |
| Q2 2018 | +3,400 | Add 8.45% | 43,648 | $5.54 |
| Q1 2018 | +40,248 | New Buy | 40,248 | $7.90 |
Renaissance Technologies (RenTech)'s Xtant Medical Holdings Investment FAQs
Renaissance Technologies (RenTech) first purchased Xtant Medical Holdings, Inc. (XTNT) in Q1 2018, acquiring 40,248 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Xtant Medical Holdings, Inc. (XTNT) for 33 quarters since Q1 2018.
Renaissance Technologies (RenTech)'s largest addition to Xtant Medical Holdings, Inc. (XTNT) was in Q1 2021, adding 921,771 shares worth $2.18 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 987,410 shares of Xtant Medical Holdings, Inc. (XTNT), valued at approximately $550,975.
As of the Q1 2026 filing, Xtant Medical Holdings, Inc. (XTNT) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Xtant Medical Holdings, Inc. (XTNT) was 1,012,000 shares, as reported at the end of Q2 2021.